Commences Production at New EU-GMP Hormone Facility in Ahmedabad

Corona Remedies has commenced commercial production at its new EU-GMP approved Women's Hormone manufacturing facility in Bhayla, Ahmedabad. Spread across 1 lakh sq ft, the facility has annual capacity of 194 million tablets and capsules and 1.5 million ointments and gels. The company says in-house hormone manufacturing capacity will rise by nearly 20%. The plant produces tablets, soft gel capsules, ointments, and gels using 21 CFR-compliant equipment and Quality by Design systems.